Weiss Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
GIM
PAI
TCM
Weiss Asset Management's BLUE Position: Q1 2024 in Review
Weiss Asset Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 37,500 shares — an estimated $1.03M sold.
Weiss Asset Management first reported a position in BLUE in Q4 2023 and held it in 1 quarter. The position peaked at $1.03M in Q4 2023. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.
- Weiss Asset Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
- Weiss Asset Management sold 37,500 bluebird bio shares in Q1 2024, an estimated $1.03M.
- Weiss Asset Management first reported a position in bluebird bio in Q4 2023 and held it in 1 quarter.
- Weiss Asset Management's bluebird bio position peaked at $1.03M in Q4 2023.
- 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.
Based on Weiss Asset Management's 13F filing for Q1 2024, filed 13 May 2024.